Xtl Bio Financial Overview
Xtl Bio's market cap is currently 24.68M. The company's EPS TTM is -0.005; its P/E ratio is -6.24; Xtl Bio is scheduled to report earnings on ―, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.